Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy - Borštnar, Simona (Radiology and oncology (Ljubljana), 2022)
Keywords: advanced breast cancer; CDK4/6 inhibitor; HER2-; HR+; inhibitor CDK4/6; napredovali rak dojke; ribociclib